UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 358

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

European heart journal, 2002-08, Vol.23 (15), p.1190-1201

2002

Volltextzugriff (PDF)

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

Diabetic medicine, 2011-11, Vol.28 (11), p.1343-1351

2011

Volltextzugriff (PDF)

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

Clinical and applied thrombosis/hemostasis, 2019, Vol.25, p.1076029619883946-1076029619883946

2019

Volltextzugriff (PDF)

Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry

International journal of clinical practice (Esher), 2013-10, Vol.67 (10), p.1005-1014

2013

Volltextzugriff (PDF)

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions

Clinical research in cardiology, 2020-12, Vol.109 (12), p.1585-1587

2020

Volltextzugriff (PDF)

Cardiovascular risk factors and clinical presentation in acute coronary syndromes

Heart (British Cardiac Society), 2005-09, Vol.91 (9), p.1141-1147

2005

Volltextzugriff (PDF)

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

European heart journal, 2006-04, Vol.27 (7), p.789-795

2006

Volltextzugriff (PDF)

Hypercholesterolemia - Where are we today? Where are we going?

Herz, 2016-08, Vol.41 (5), p.413-420

2016

Volltextzugriff (PDF)

Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?

Herz, 2014-11, Vol.39 (7), p.798-802

2014

Volltextzugriff (PDF)

Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort

Acta diabetologica, 2015-12, Vol.52 (6), p.1093-1101

2015

Volltextzugriff (PDF)

Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR)

European heart journal, 2001-10, Vol.22 (19), p.1794-1801

2001

Volltextzugriff (PDF)

The patient with acute myocardial infarction who does not receive reperfusion treatment

Heart (British Cardiac Society), 2001-09, Vol.86 (3), p.243-245

2001

Volltextzugriff (PDF)

Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study

Acta diabetologica, 2003-12, Vol.40 Suppl 2, p.S343-s347

2003

Volltextzugriff (PDF)

Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry

Herz, 2012-05, Vol.37 (3), p.294-300

2012

Volltextzugriff (PDF)

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry

Journal of the American College of Cardiology, 2001-06, Vol.37 (7), p.1827-1835

2001

Volltextzugriff (PDF)

Effectiveness of the glycoprotein iib/iiia antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center

Clinical research in cardiology, 2003-06, Vol.92 (6), p.438-444

2003

Volltextzugriff (PDF)

Hypercholesterinämie – Wo stehen wir heute? Wo wollen wir hin?

Herz, 2016-08, Vol.41 (5), p.413-420

2016

Volltextzugriff (PDF)

P651Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice - Results of DYSIS

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice

Heart (British Cardiac Society), 2006-10, Vol.92 (10), p.1484-1489

2006

Volltextzugriff (PDF)

Moderne Lipid-Therapie heute und morgen: Anti-PCSK9: Ein „magic bullet“-Konzept nach Paul Ehrlich

Herz, 2016-06, Vol.41 (4), p.271-272

2016

Volltextzugriff (PDF)

Modern Lipid therapy today and tomorrow: anti-PCSK9 : A magic bullet concept following Paul Ehrlich

Herz, 2016-06, Vol.41 (4), p.271-272

2016

Volltextzugriff (PDF)

In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte

Heart (British Cardiac Society), 2005-08, Vol.91 (8), p.1041-1046

2005

Volltextzugriff (PDF)

The role of cardiac registries in evidence-based medicine

European heart journal, 2010-03, Vol.31 (5), p.525-529

2010

Volltextzugriff (PDF)

Decreasing hospital mortality between 1994 and 1998 in patients with acute Myocardial Infarction treated with Primary angioplasty but not in patients treated with intravenous thrombolysis : Results from the pooled data of the Maximal Individual Therapy in acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR)

Journal of the American College of Cardiology, 2000-12, Vol.36 (7), p.2064-2071

2000

Volltextzugriff (PDF)

P5383Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

1 – 25 von 358

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Englisch
(302)
Deutsch
(56)
Spanisch
(1)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(166)
Science & Technology
(160)
Life Sciences & Biomedicine
(156)
Female
(142)
Male
(140)
Cardiovascular System & Cardiology
(128)
Aged
(122)
Middle Aged
(122)
Cardiac & Cardiovascular Systems
(120)
Treatment Outcome
(69)
Cardiology
(67)
Registries
(61)
Prospective Studies
(59)
Risk Factors
(59)
Biological And Medical Sciences
(56)
Cardiovascular
(56)
Medical Sciences
(56)
Internal Medicine
(53)
Coronary Heart Disease
(50)
Cardiology. Vascular System
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions

Cardiovascular risk factors and clinical presentation in acute coronary syndromes

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

Hypercholesterolemia - Where are we today? Where are we going?

Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?

Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort

The patient with acute myocardial infarction who does not receive reperfusion treatment

Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study

Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry

Effectiveness of the glycoprotein iib/iiia antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center

Hypercholesterinämie – Wo stehen wir heute? Wo wollen wir hin?

P651Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice - Results of DYSIS

Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice

Moderne Lipid-Therapie heute und morgen: Anti-PCSK9: Ein „magic bullet“-Konzept nach Paul Ehrlich

Modern Lipid therapy today and tomorrow: anti-PCSK9 : A magic bullet concept following Paul Ehrlich

The role of cardiac registries in evidence-based medicine

P5383Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica

Suchergebnisse filtern